About the network
The main objectives of ERLI-Net are to carry out virological surveillance of human influenza and to ensure that data are shared through the European Influenza Surveillance Network (EISN) reporting mechanisms in a timely manner.
Influenza laboratory quality control
In accordance with the Key Tasks, ERLI-Net laboratories should participate in external quality assurance (EQA) schemes. EQA panels are distributed by both ERLI-Net and the WHO.
Influenza virus characterisation, Summary Europe, July 2017
In the course of the 2016–17 influenza season, nearly 146 000 influenza detections have been reported across the WHO European Region.
Influenza virus characterisation, Summary Europe, September 2017
In the course of the 2016–17 influenza season, over 146 000 influenza detections across the WHO Europe Region have been reported.
WHO: Global influenza updates
The summaries of global surveillance are based on data gathered through global and regional data sharing platforms, and direct reports from Member States.
WHO Global Influenza Surveillance and Response System (GISRS)
WHO GISRS monitors the evolution of influenza viruses and provides recommendations in areas including laboratory diagnostics, vaccines, antiviral susceptibility and risk assessment. WHO GISRS also serves as a global alert mechanism for the emergence of influenza viruses with pandemic potential.
Joint WHO/Europe–ECDC Annual European Influenza Surveillance Meeting, 2018
The joint annual influenza surveillance meeting by ECDC and the WHO Regional Office for Europe took place on 6 - 8 June 2018 in Copenhagen, Denmark. Invited participants were epidemiological and virological surveillance experts nominated by national health authorities as well as representatives from international institutions, covering the 53 countries of the EU/EEA and the WHO European region. The meeting was by invitation only.